Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: the SMART/EST Women's Project

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2006 Oct 10

PMID 17028992

Citations 33

Authors

Deborah L Jones

Shvawn McPherson-Baker

David Lydston

Joanne Camille

Elizabeth Brondolo

Jonathan N Tobin

Stephen M Weiss

Affiliations

Soon will be listed here.

Abstract

This intervention sought to improve overall quality of life and health behavior in women living with human immunodeficiency virus (HIV). We contrasted the effect of a group cognitive behavioral stress management expressive supportive therapy (CBSM+) intervention plus a healthier lifestyles (HL) component with an individual educational/informational format plus HL on HIV-medication adherence. Women, n = 237, predominantly African-American and Latina, living with HIV were recruited from Miami, New York and New Jersey and randomized to group or individual conditions (ten weekly sessions) plus group or individual HL, i.e., four conditions. Women reported relatively high levels of adherence at baseline. Participants in any of the group conditions increased self-reported adherence and emotion-focused coping skills in comparison with individual participation. This study suggests that group interventions may be an important adjunct in increasing medication adherence for HIV positive women.

Citing Articles

Lessons Learned from a Community-led, Pilot Teletherapy Group for Older Women Living with Depression and HIV.

Breslow A, Lopez M, Warren B, Levin J, Sharma A, Watnick D AIDS Behav. 2024; 28(12):4079-4093.

PMID: 39222185 PMC: 11586307. DOI: 10.1007/s10461-024-04468-y.

Discrimination and adherence in a cross-sectional study of Latino sexual minority men with HIV: Coping with discrimination as a mediator and coping self-efficacy as a moderator.

Barreras J, Bogart L, MacCarthy S, Klein D, Pantalone D J Behav Med. 2023; 46(6):1057-1067.

PMID: 37392342 PMC: 10577103. DOI: 10.1007/s10865-023-00426-6.

Mental Health in Women Living With HIV: The Unique and Unmet Needs.

Waldron E, Burnett-Zeigler I, Wee V, Ng Y, Koenig L, Pederson A J Int Assoc Provid AIDS Care. 2021; 20:2325958220985665.

PMID: 33472517 PMC: 7829520. DOI: 10.1177/2325958220985665.

Mind-body practices for people living with HIV: a systematic scoping review.

Ramirez-Garcia M, Gagnon M, Colson S, Cote J, Flores-Aranda J, Dupont M BMC Complement Altern Med. 2019; 19(1):125.

PMID: 31185970 PMC: 6560810. DOI: 10.1186/s12906-019-2502-z.

A Systematic Review and Meta-analysis of Antiretroviral Therapy (ART) Adherence Interventions for Women Living with HIV.

Pellowski J, Price D, Harrison A, Tuthill E, Myer L, Operario D AIDS Behav. 2018; 23(8):1998-2013.

PMID: 30443806 PMC: 6520201. DOI: 10.1007/s10461-018-2341-9.

References

Spiegel D, Bloom J, YALOM I . Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry. 1981; 38(5):527-33. DOI: 10.1001/archpsyc.1980.01780300039004. View

Hill Z, Kendall C, Fernandez M . Patterns of adherence to antiretrovirals: why adherence has no simple measure. AIDS Patient Care STDS. 2003; 17(10):519-25. DOI: 10.1089/108729103322494311. View

Baron R, Kenny D . The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51(6):1173-82. DOI: 10.1037//0022-3514.51.6.1173. View

Carver C, Scheier M, Weintraub J . Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989; 56(2):267-83. DOI: 10.1037//0022-3514.56.2.267. View

Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E . HIV-1 drug resistance in newly infected individuals. JAMA. 1999; 282(12):1135-41. DOI: 10.1001/jama.282.12.1135. View

Pakenham K . Specification of social support behaviours and network dimensions along the HIV continuum for gay men. Patient Educ Couns. 1998; 34(2):147-57. DOI: 10.1016/s0738-3991(97)00104-3. View

Kievits T, VAN Gemen B, van Strijp D, Schukkink R, Dircks M, Adriaanse H . NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J Virol Methods. 1991; 35(3):273-86. DOI: 10.1016/0166-0934(91)90069-c. View

Gordillo V, Del Amo J, Soriano V, Gonzalez-Lahoz J . Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999; 13(13):1763-9. DOI: 10.1097/00002030-199909100-00021. View

Segal-Isaacson C, Tobin J, Weiss S, Brondolo E, Vaughn A, Wang C . Improving dietary habits in disadvantaged women with HIV/AIDS: the SMART/EST women's project. AIDS Behav. 2006; 10(6):659-70. PMC: 2587452. DOI: 10.1007/s10461-006-9115-5. View

10.

Laperriere A, Ironson G, Antoni M, Pomm H, Jones D, Ishii M . Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women's project. J Health Psychol. 2005; 10(2):223-31. PMC: 2587455. DOI: 10.1177/1359105305049772. View

11.

CARPENTER C, Cooper D, Fischl M, Gatell J, Gazzard B, Hammer S . Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000; 283(3):381-90. DOI: 10.1001/jama.283.3.381. View

12.

Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T . Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000; 19(2):124-33. View

13.

Paterson D, Swindells S, Mohr J, BRESTER M, Vergis E, Squier C . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133(1):21-30. DOI: 10.7326/0003-4819-133-1-200007040-00004. View

14.

Malow R, Penedo F, Jones D, Schneiderman N, Klimas N . Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care. 2000; 12(4):399-404. DOI: 10.1080/09540120050123792. View

15.

Bangsberg D, Hecht F, Clague H, Charlebois E, Ciccarone D, Chesney M . Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 26(5):435-42. DOI: 10.1097/00126334-200104150-00005. View

16.

Kalichman S, Rompa D, DiFonzo K, Simpson D, Austin J, Luke W . HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills model of health behavior. J Assoc Nurses AIDS Care. 2001; 12(4):58-67. DOI: 10.1016/S1055-3290(06)60217-3. View

17.

Stone V, Hogan J, Schuman P, Rompalo A, Howard A, Korkontzelou C . Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001; 28(2):124-31. DOI: 10.1097/00042560-200110010-00003. View

18.

Hogg R, Yip B, Chan K, Wood E, Craib K, OShaughnessy M . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001; 286(20):2568-77. DOI: 10.1001/jama.286.20.2568. View

19.

Wagner G, Remien R, Carballo-Dieguez A, Dolezal C . Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care. 2002; 14(1):105-9. DOI: 10.1080/09540120220097973. View

20.

Sankar A, Luborsky M, Schuman P, Roberts G . Adherence discourse among African-American women taking HAART. AIDS Care. 2002; 14(2):203-18. PMC: 4209598. DOI: 10.1080/09540120220104712. View